Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Hypoxia × Biopsy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 22 Neoplasms 13 Prostatic Neoplasms 11 Lung Neoplasms 10 Uterine Cervical Neoplasms 8 Carcinoma, Non-Small-Cell Lung 6 Squamous Cell Carcinoma of Head and Neck 5 Stomach Neoplasms 4 Pancreatic Neoplasms 4 Head and Neck Neoplasms 4 Carcinoma, Squamous Cell 4 Uterine Cervical Dysplasia 3 Skin Neoplasms 3 Rectal Neoplasms 3 Melanoma 3 Glioma 3 Glioblastoma 3 Disease 3 Colorectal Neoplasms 3 Central Nervous System Neoplasms 3 Carcinoma, Intraductal, Noninfiltrating 3 Breast Neoplasms, Male 3 Breast Carcinoma In Situ 3 Barrett Esophagus 3 Thyroid Neoplasms 2 Sarcoma 2 Precancerous Conditions 2 Oligodendroglioma 2 Neuroectodermal Tumors, Primitive 2 Neoplasm Metastasis 2

Interventions

fluoroazomycin arabinoside 3 3-fluoro-2-(4-((2-nitro-1H-imidazol-1-yl)methyl)-1H-1,2,3-triazol-1-yl)propan-1-ol 3 pimonidazole 2 Propofol 2 gadobutrol 1 Sevoflurane 1 Radiotherapy 1 Pancreaticoduodenectomy 1 Oxygen 1 Ketamine 1 Gemcitabine 1 Furosemide 1 Exercise 1 Diagnostic Imaging 1 Blood Specimen Collection 1 Biopsy 1 4-methylbenzenesulfonic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02157246 2017-03-13

RHYTHM-I

University of Oxford

Phase NA Completed

Gastrointestinal

Hypoxia, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡